Objectives To determine the effects of cannabis, cannabinoids, and their administration
routes on pain and adverse euphoria events. Data sources A systematic search was …

Background: The therapeutic use of cannabis and cannabis-based medicines raises safety
concerns for patients, clinicians, policy-makers, insurers, researchers and regulators …

Pharmacotherapies for cannabis dependence - Nielsen, S - 2019 | Cochrane Library Skip to
Content Cookies Our site uses cookies to improve your experience. You can find out more …

In many communities, cannabis is perceived as a low-risk drug, leading to political lobbying
to decriminalise its use. Acute and chronic cannabis use has been shown to be harmful to …

Background Whilst access to cannabis-based medicinal products (CBMPs) has increased
globally subject to relaxation of scheduling laws globally, one of the main barriers to …

Randomised controlled trials (RCTs) have long been considered the gold standard of
medical evidence. In relation to cannabis based medicinal products (CBMPs), this focus on …

Rationale Certifications for medical cannabis are generally restricted to a small number of
specific medical conditions, yet patients frequently report symptoms of pain, anxiety, and …

Objective: To compile and synthesize the available literature describing medical cannabis
use across various disease states. Data Sources: PubMed, EBSCO, and Google Scholar …

Introduction: Cannabis has been used for medical purposes across the world for centuries.
As states and countries implement medical and recreational cannabis policies, increasing …

Objective: Debilitating pain, occurring in 50–70% of multiple sclerosis (MS) patients, is
poorly understood and infrequently studied. We summarized efficacy and safety data of …